Company Analysis
Sign in

Baird Medical Investment Holdings Ltd (BDMD)

Nasdaq: BDMD · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2023
Full chart Alerts Compare
Grade4.0
◀ Past 4.5● Present 3.5▶ Future 4.3
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$22.5M-39.2%
Net income-$27.5M-318.6%
Earnings per share$-0.98-271.9%
Operating cash flow-$1.3M+78.7%
Cash$565,817-81.0%
Debt$6.1M+76.8%
Shareholders’ equity$31.2M-21.5%
Shares, diluted27.8M+27.3%
Return on equity-88.2%
The recordfrom its filings
Filings in 202630
Newest filingNov 5 · 6-K
Annual reportApr 24, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
22232425
As filed, in USD. Nothing here is a forecast.

News

Oct 1, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Sep 24, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Aug 17, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Aug 17, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BDMD · research, not advice